P
Peng Xue
Researcher at Southwest University
Publications - 132
Citations - 3737
Peng Xue is an academic researcher from Southwest University. The author has contributed to research in topics: Photothermal therapy & Drug delivery. The author has an hindex of 27, co-authored 114 publications receiving 2162 citations. Previous affiliations of Peng Xue include Nanyang Technological University.
Papers
More filters
Journal ArticleDOI
Paper-Based Microfluidic Electrochemical Immunodevice Integrated with Nanobioprobes onto Graphene Film for Ultrasensitive Multiplexed Detection of Cancer Biomarkers
TL;DR: The novel signal-amplified strategy proposed in this report greatly enhanced the detection of cancer biomarkers and exhibited good stability, reproducibility, and accuracy and thus had potential applications in clinical diagnostics.
Journal ArticleDOI
A paper-based microfluidic electrochemical immunodevice integrated with amplification-by-polymerization for the ultrasensitive multiplexed detection of cancer biomarkers
TL;DR: The results show that the proposed strategy offers great promises in providing a sensitive and cost-effective solution for biosensing applications.
Journal ArticleDOI
Nano metal–organic framework (NMOF)-based strategies for multiplexed microRNA detection in solution and living cancer cells
TL;DR: This miRNA sensor enables the quantitative and highly specific detection of multiplexed miRNAs in living cancer cells, but it also allows the precise and in situ monitoring of the spatiotemporal changes of miRNA expression.
Journal ArticleDOI
Highly specific and ultrasensitive graphene-enhanced electrochemical detection of low-abundance tumor cells using silica nanoparticles coated with antibody-conjugated quantum dots.
TL;DR: A dual signal amplification immunosensing strategy that offers high sensitivity and specificity for the detection of low-abundance tumor cells was designed and demonstrated, indicating its wide range of potential applications in clinical and molecular diagnostics.
Journal ArticleDOI
ROS-responsive cyclodextrin nanoplatform for combined photodynamic therapy and chemotherapy of cancer
TL;DR: This work designed a highly sensitive reactive oxygen species (ROS)-responsive polymer PCP which encapsulated doxorubicin (DOX) and purpurin 18 (P18) to achieve the synergy of photodynamic and chemotherapy to provide an effective strategy for the application of collaborative anti-tumor therapy.